We are live on ! Find out more
FNYS

First New York Securities Portfolio holdings

AUM $53.7M
1-Year Est. Return 57.01%
This Fund
S&P 500
This Quarter Est. Return
+6.13%
1 Year Est. Return
+57.01%
3 Year Est. Return
+119.4%
5 Year Est. Return
10 Year Est. Return
AUM
$97M
AUM Growth
-$107M
Cap. Flow
-$121M
Cap. Flow %
-125.07%
Top 10 Hldgs %
67.23%
Holding
517
New
131
Increased
32
Reduced
23
Closed
325

Top Sells

Rank Stock Value
1
VOD icon
Vodafone
VOD
+$16.9M
2
ALV icon
Autoliv
ALV
+$9.14M
3
EQNR icon
Equinor
EQNR
+$7.71M
4
VZ icon
Verizon
VZ
+$6.87M
5
NOK icon
Nokia
NOK
+$4.97M

Sector Composition

Rank Sector Weight
1 Healthcare 29.53%
2 Financials 20.44%
3 Miscellaneous 18.7%
4 Real Estate 11.02%
5 Consumer Discretionary 7.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FRX
1
DELISTED
FOREST LABORATORIES INC
FRX
$18.4M 19.01%
+186,236
New +$17.4M
FNF icon
2
Fidelity National Financial
FNF
$12.8B
$16.8M 17.35%
+899,784
New +$16.8M
WY icon
3
Weyerhaeuser
WY
$17B
$10.7M 11%
+322,500
New +$9.75M
LVNTA
4
DELISTED
Liberty Interactive Corporation Series A Liberty Ventures
LVNTA
$4.43M 4.56%
+122,100
New +$3.84M
PARA
5
PUT
DELISTED
Paramount Global Class B
PARA
$3.44M 3.55%
+3,000
New +$179K
OUT icon
6
PUT
Outfront Media
OUT
$5.21B
$3.03M 3.13%
+3,037
New +$71.6K
BMY icon
7
Bristol-Myers Squibb
BMY
$136B
$2.38M 2.45%
+49,000
New +$2.41M
SI
8
DELISTED
SIEMENS AKTIENGESELLSCHAFT ADS
SI
$2.35M 2.43%
+17,800
New +$2.38M
BMRN icon
9
BioMarin Pharmaceuticals
BMRN
$12.5B
$2.03M 2.09%
+32,609
New +$1.97M
NVO
10
Novo Nordisk
NVO
$202B
$1.62M 1.67%
70,000
+15,000
+27% +$331K
WY icon
11
PUT
Weyerhaeuser
WY
$17B
$1.52M 1.57%
+3,258
New +$98.5K
STM icon
12
STMicroelectronics
STM
$44B
$1.34M 1.39%
151,233
+121,721
+412% +$1.14M
FMS icon
13
Fresenius Medical Care
FMS
$12.3B
$1.29M 1.33%
38,602
+21,602
+127% +$720K
ITB icon
14
iShares US Home Construction ETF
ITB
$2.25B
$1.24M 1.28%
50,000
+30,000
+150% +$716K
DG icon
15
Dollar General
DG
$27.1B
$1.13M 1.17%
+19,750
New +$1.13M
DB icon
16
Deutsche Bank
DB
$75.8B
$1.08M 1.11%
+34,253
New +$1.22M
IDIX
17
CALL
DELISTED
IDENIX PHARMACEUTICALS INC
IDIX
$1.07M 1.1%
+586
New +$6.11K
TVTX icon
18
Travere Therapeutics
TVTX
$6.19B
$974K 1%
+83,000
New +$1.12M
SINA
19
DELISTED
Sina Corp
SINA
$971K 1%
19,500
-500
-3% -$24.5K
FRA icon
20
BlackRock Floating Rate Income Strategies Fund
FRA
$392M
$965K 0.99%
65,857
+7,704
+13% +$111K
APPS icon
21
Digital Turbine
APPS
$1.34B
$954K 0.98%
241,578
+131,314
+119% +$481K
CVEO icon
22
Civeo
CVEO
$342M
$751K 0.77%
+2,500
New +$748K
KBH icon
23
KB Home
KBH
$3.36B
$654K 0.67%
+35,000
New +$586K
BMRN icon
24
CALL
BioMarin Pharmaceuticals
BMRN
$12.5B
$641K 0.66%
+923
New +$55.8K
ATML
25
DELISTED
ATMEL CORP
ATML
$600K 0.62%
64,000
-5,000
-7% -$41.8K

Similar funds

First New York Securities's Q2 2014 Portfolio in Review

As of Q2 2014, First New York Securities held 517 positions worth $97M, down 52% from $204M the previous quarter. Its ten largest holdings account for 67% of the portfolio.

First New York Securities withdrew a net $121M in Q2 2014, closing 325 positions and reducing 23 holdings. Its most notable exit was Vodafone, an estimated $16.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, up from 9.2% a quarter earlier, followed by Financials and Miscellaneous.

Against the trend, First New York Securities opened a new position in FOREST LABORATORIES INC worth $18.4M.

  • First New York Securities's largest Q2 2014 buy was FOREST LABORATORIES INC: 186,236 shares worth $18.4M.
  • First New York Securities added most to STMicroelectronics in Q2 2014, an estimated $1.14M increase.
  • First New York Securities's biggest Q2 2014 reduction was Shire pic, cutting an estimated $4.09M.
  • First New York Securities fully exited Vodafone in Q2 2014, selling an estimated $16.9M.
  • First New York Securities's ten largest holdings make up 67% of its $97M portfolio in Q2 2014.
  • First New York Securities opened 131 new positions and closed 325 in Q2 2014.
  • First New York Securities's portfolio value fell 52% quarter-over-quarter to $97M.

Based on First New York Securities's 13F filing for Q2 2014, filed 15 Aug 2014.